Thousands of experimental Ebola vaccine doses from British GSK and US NewLink should be ready for use by early 2015 in countries affected by the epidemic, the World Health Organisation said on Friday.
Subscribe to Blog via Email
Reader Interactions
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Leave a Reply